Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Greer

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Frontiers in Oncology|October 27, 2022
Quality assurance for MRI-only radiation therapy: A voxel-wise population-based methodology for image and dose assessment of synthetic CT generation methodsHilda Chourak, Anaïs Barateau, Safaa Tahri, et al.
Radiation Oncology (London, England)|March 19, 2022
Validation of an MRI-only planning workflow for definitive pelvic radiotherapyLaura M O'Connor, Jason A Dowling, Jae Hyuk Choi, et al.
International Journal of Radiation Oncology, Biology, Physics|September 11, 2019
Comparison of Deep Learning-Based and Patch-Based Methods for Pseudo-CT Generation in MRI-Based Prostate Dose PlanningAxel Largent, Anaïs Barateau, Jean-Claude Nunes, et al.
Medical Physics|June 29, 2023
AAPM Task Group Report 307: Use of EPIDs for Patient-Specific IMRT and VMAT QANesrin Dogan, Ben J Mijnheer, Kyle Padgett, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2009
Measuring time to biochemical failure in the TROG 96.01 trial: when should the clock start ticking?James W Denham, Allison Steigler, Mahesh Kumar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2017
A virtual dosimetry audit - Towards transferability of gamma index analysis between clinical trial QA groupsMohammad Hussein, Enrico Clementel, David J Eaton, et al.
The Lancet. Oncology|October 22, 2008
Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trialJames W Denham, Allison Steigler, Chantelle Wilcox, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2015
Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI SequencesJason A Dowling, Jidi Sun, Peter Pichler, et al.
International Journal of Radiation Oncology, Biology, Physics|January 30, 2009
Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancerJames W Denham, Mahesh Kumar, Paul S Gleeson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2011
MRI-guided prostate radiation therapy planning: Investigation of dosimetric accuracy of MRI-based dose planningJonathan Lambert, Peter B Greer, Fred Menk, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Frontiers in Oncology|October 27, 2022
Quality assurance for MRI-only radiation therapy: A voxel-wise population-based methodology for image and dose assessment of synthetic CT generation methodsHilda Chourak, Anaïs Barateau, Safaa Tahri, et al.
Radiation Oncology (London, England)|March 19, 2022
Validation of an MRI-only planning workflow for definitive pelvic radiotherapyLaura M O'Connor, Jason A Dowling, Jae Hyuk Choi, et al.
International Journal of Radiation Oncology, Biology, Physics|September 11, 2019
Comparison of Deep Learning-Based and Patch-Based Methods for Pseudo-CT Generation in MRI-Based Prostate Dose PlanningAxel Largent, Anaïs Barateau, Jean-Claude Nunes, et al.
Medical Physics|June 29, 2023
AAPM Task Group Report 307: Use of EPIDs for Patient-Specific IMRT and VMAT QANesrin Dogan, Ben J Mijnheer, Kyle Padgett, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2009
Measuring time to biochemical failure in the TROG 96.01 trial: when should the clock start ticking?James W Denham, Allison Steigler, Mahesh Kumar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2017
A virtual dosimetry audit - Towards transferability of gamma index analysis between clinical trial QA groupsMohammad Hussein, Enrico Clementel, David J Eaton, et al.
The Lancet. Oncology|October 22, 2008
Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trialJames W Denham, Allison Steigler, Chantelle Wilcox, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2015
Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI SequencesJason A Dowling, Jidi Sun, Peter Pichler, et al.
International Journal of Radiation Oncology, Biology, Physics|January 30, 2009
Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancerJames W Denham, Mahesh Kumar, Paul S Gleeson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2011
MRI-guided prostate radiation therapy planning: Investigation of dosimetric accuracy of MRI-based dose planningJonathan Lambert, Peter B Greer, Fred Menk, et al.
Pageof 13